Date |
Product |
Disease |
Phase |
Company |
Therapeutic area |
2017-07-07
|
ARGX-111 |
|
1b |
arGEN-X (The Netherlands - Belgium) |
Cancer - Oncology |
2017-07-07
|
JX-594/TG6006 (Pexa-Vec -pexastimogene devacirepvec) and cyclophosphamide |
soft tissue sarcoma (STS), HER2 negative-breast cancer |
1-2 |
Institut Bergonié (France) Transgene (France) |
Cancer - Oncology |
2017-07-06
|
SHP654 (BAX 888) |
hemophilia A |
2 |
Shire (UK - USA) |
Rare diseases - Genetic diseases - Hematological diseases |
2017-07-06
|
dMAb® product for flu |
flu |
preclinical |
Inovio Pharmaceuticals (USA - PA) |
Infectious diseases |
2017-07-05
|
|
|
|
|
|
2017-07-05
|
AR101 |
peanut allergy |
3 |
Aimmune Therapeutics (USA - CA) previously Allergen Research Corporation (ARC) |
Allergic diseases |
2017-07-05
|
PRS-080 |
Functional Iron Deficiency anemia |
2a |
Pieris (Germany) |
Hematological diseases - Metabolic diseases |
2017-07-05
|
pembrolizumab (MK-3475) and pomalidomide |
multiple myeloma |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2017-07-05
|
pembrolizumab (MK-3475) |
multiple myeloma |
3 |
Merck&Co (USA - NJ) |
Cancer - Oncology |
2017-07-05
|
BGB-3111 |
B-cell malignancies |
1 |
BeiGene (China) |
Cancer - Oncology |
2017-07-05
|
AsiDNA™ |
|
preclinical |
Onxeo (France) |
Cancer - Oncology |
2017-07-05
|
AM-111 |
idiopathic sudden sensorineural hearing loss |
3 |
Auris Medical (Switzerland) |
Otorhinolaryngology |
2017-07-03
|
vilaprisan (BAY1002670) |
symptomatic uterine fibroids |
3 |
Bayer Healthcare (Germany) |
Gynecology - Women's health |
2017-07-03
|
dasiglucagon (ZP4207) |
severe hypoglycemia in type 1 diabetes patients |
3 |
Zealand Pharma (Denmark) |
Metabolic diseases |
2017-07-01
|
risdiplam - RO7034067/RG7916 |
type 2 and type 3 spinal muscular atrophy (SMA) |
2 |
PTC Therapeutics (USA - NJ) Roche (Switzerland) |
Rare diseases - Genetic diseases - Neuromuscular diseases |
2017-06-29
|
SD-809 - deutetrabenazine |
tardive dyskinesia |
3 |
Teva Pharmaceutical Industries (Israel) |
Neurological diseases - CNS diseases |
2017-06-28
|
gemcabene (CI-1027) |
homozygous familial hypercholesterolemia (HoFH) |
2b |
Gemphire Therapeutics (USA - Mich) |
Rare diseases - Genetic diseases - Cardiovascular diseases |
2017-06-28
|
remimazolam |
procedural sedation in patients undergoing bronchoscopy |
3 |
Paion (Germany) |
CNS diseases |
2017-06-28
|
CX-2009 |
advanced solid tumors including non-small cell lung cancer, breast cancer, ovarian cancer, endometrial cancer, cholangiocarcinoma (bile duct cancer), head and neck cancer and castration-resistant prostate cancer |
1-2 |
CytomX Therapeutics (USA - CA) |
Cancer - Oncology |
2017-06-27
|
MVT-1075 (177Lu-CHX-A-DTPA-HuMab5B1) |
recurrent pancreatic cancer and other CA19-9 positive malignancies |
1 |
MabVax Therapeutics (USA - CA) |
Cancer - Oncology |